Polymerase chain reaction detection of HIV-1 2-LTR circular DNA may predict CD4 decline. NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Polymerase chain reaction detection of HIV-1 2-LTR circular DNA may predict CD4 decline.

Abstr Gen Meet Am Soc Microbiol. 1994;94:555 (abstract no. C-368). Unique Identifier : AIDSLINE ASM94/94313109
Byrne BC; Parisi JM; Baxter JD; UMDNJ/RWJ Medical School, Camden 08103.


Abstract: CD4(+)-T cell counts reflect a consequence of HIV infection but are not markers of viral activity. We seek ways to monitor aspects of HIV infection as potential tools in clinical trials of antiretroviral agents or clinical management of infected patients. HIV RNA genomes are reverse transcribed into double stranded linear DNA molecules following cellular infection. The linear molecule may integrate into the host chromosome initiating a new focus of infection or, linking the 5' and 3' LTR regions, circularize. Proviral 2-LTR circles are apparent dead ends in the retroviral life cycle, but provide unique targets for polymerase chain reaction (PCR). Appropriately designed primers within the LTR will fail to produce product from linear proviral DNA because (1) they are directed outward from one another or (2) they span too large a sequence (ca. 9KB) to form PCR product. Circles, by their topography, yield PCR products and may be used generically for the low molecular weight proviral DNA indicative of recent retroviral activity. We designed nested primers within the LTR of HIV-1 to amplify closed circular DNA and retrospectively selected 12 samples of peripheral blood mononuclear cells from 12 patients having CD4 counts of approximately 500, approximately 200 or approximately 20 cells/mm3 at the time of sampling. These patients thereafter either exhibited stable or declining counts. Quantitative PCR for HIV circles was most intense for two patients in the approximately 500 CD4 class; these two patients also showed the most profound rate of CD4 decline. Abundant closed circular DNA detected by PCR may be a marker of retroviral activity that heralds imminent CD4 decline and might have implications for antiretroviral therapy.
Keywords: Acquired Immunodeficiency Syndrome/CLASSIFICATION/*IMMUNOLOGY CD4-Positive T-Lymphocytes/*IMMUNOLOGY/MICROBIOLOGY DNA, Circular/*ANALYSIS DNA, Viral/*ANALYSIS Human *HIV Long Terminal Repeat HIV-1/GENETICS/*ISOLATION & PURIF HIV-2/GENETICS/*ISOLATION & PURIF Polymerase Chain Reaction/*METHODS Predictive Value of Tests ABSTRACTKWDacquiredimmunodeficiencysyndrome/classification/KWDimmunologycd4-positivet-lymphocytes/KWDimmunology/microbiologydna,circular/KWDanalysisdna,viral/KWDanalysishumanKWDhivlongterminalrepeathiv-1/genetics/KWDisolation&purifhiv-2/genetics/KWDisolation&purifpolymerasechainreaction/KWDmethodspredictivevalueoftestsabstract
941030
M94A0845

Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .